article_snippet: A breakthrough study found that the cholesterol-lowering drugs improved outcomes for those suffering from the common cardiac disorder.
article_snippet: The medication has already been linked to a reduction in heart attacks.
article_snippet: Doctors once prescribed the drug to those with a 30 per cent risk of a heart attack within the next decade, but this was cut to a 20 per cent risk in 2005.
article_snippet: Cholesterol-lowering drugs block bad cholesterol more powerfully and in a different way than existing drugs .
article_snippet: A new type of cholesterol-lowering drug may halve the risk of a heart attack or stroke, new research suggests.
article_snippet: People taking the experimental drug for high cholesterol were half as likely to die or suffer a heart attack or stroke as those taking conventional statins.
article_snippet: The results could offer an alternative to the estimated one in three Westerners with high cholesterol who have been unable to manage Westerners condition with diet, exercise and statin drugs currently on the market.
article_snippet: The results are 'really impressive and very encouraging' for Cholesterol-lowering drugs, said one independent expert, Dr Judith Hochman of NYU Langone Medical Center.
article_snippet: The U.S. government will decide this summer whether to allow two of Cholesterol-lowering drugs on the market.
article_snippet: Cholesterol-lowering drugs are evolocumab, which Amgen wants to call Repatha, and alirocumab, which Regeneron Pharmaceuticals and Sanofi have named Praluent.
article_snippet: Cholesterol-lowering drugs lower LDL or bad cholesterol
article_snippet: more powerfully and in a different way than existing drugs, by blocking PCSK9, a substance that interferes with the liver's ability to remove cholesterol from the blood.